Nov 30, 2023The REDUSE Trial is funded by The Swedish Research CouncilUpdated: Jan 11We are very pleased to announce that the Swedish Research Council (Vetenskapsrådet) has granted the REDUSE Trial a total of 19.3 MSEK over the period 2024 - 2027. Read more here: https://www.vr.se/english/swecris.html?project=2023-00257_VR#/
We are very pleased to announce that the Swedish Research Council (Vetenskapsrådet) has granted the REDUSE Trial a total of 19.3 MSEK over the period 2024 - 2027. Read more here: https://www.vr.se/english/swecris.html?project=2023-00257_VR#/
Feasibility Trial Now PublishedThe results of the REDUSE feasibility trial were published today in Critical Care. Read the full article here.
Inclusion update - ÖstersundToday (May 6), the investigation team at Östersund Hospital initiated the inclusion of participants for the REDUSE Trial.
Comments